drugset / Trial / NCT05524532
Effects of Immulina TM Supplements With PASC Patients
Phase 3
Completed
101 enrolled
University of Mississippi Medical Center
National Institute of General Medical Sciences (NIGMS) · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
This is a multi-site study that will try to determine the effects of Immulina ™, a natural dietary supplement, on blood chemicals associated with inflammation that are often increased in patients with long COVID (also called PASC).
Timeline
- Start
- 2023-07-20
- Primary completion
- 2025-07-29
- Completion
- 2025-07-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | spirulina | Unknown | 400 mg | Oral |